Kevin D. Brandt
2018 - Xtant Medical Holdings
In 2018, Kevin D. Brandt earned a total compensation of $666.3K as Chief Commercial Officer at Xtant Medical Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $76,154 |
|---|---|
| Option Awards | $165,186 |
| Salary | $176,923 |
| Stock Awards | $248,000 |
| Total | $666,263 |
Brandt received $248K in stock awards, accounting for 37% of the total pay in 2018.
Brandt also received $76.2K in non-equity incentive plan, $165.2K in option awards and $176.9K in salary.
Rankings
In 2018, Kevin D. Brandt's compensation ranked 10,910th out of 14,244 executives tracked by ExecPay. In other words, Brandt earned more than 23.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,910 out of 14,244 | 23rd |
Division Manufacturing | 4,395 out of 5,758 | 24th |
Major group Chemicals And Allied Products | 1,654 out of 2,119 | 22nd |
Industry group Drugs | 1,401 out of 1,808 | 23rd |
Industry Biological Products, Except Diagnostic Substances | 271 out of 339 | 20th |
Source: SEC filing on September 20, 2019.
Brandt's colleagues
We found three more compensation records of executives who worked with Kevin D. Brandt at Xtant Medical Holdings in 2018.
News
Xtant Medical Holdings CEO Sean Browne's 2022 pay jumps 28% to $1.1M
June 7, 2023
Xtant Medical Holdings CFO Greg Jensen's 2021 pay rises 11% to $955K
September 20, 2022
Xtant Medical Holdings CEO Sean Browne's 2020 pay jumps 146% to $4.5M
June 14, 2021
Xtant Medical Holdings CEO Carl O'Connell's 2018 pay jumps 224% to $1.8M
September 20, 2019